• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Uchibori Ryosuke  内堀 亮介

ORCIDConnect your ORCID iD *help
… Alternative Names

内堀 亮介  ウチボリ リョウスケ

UCHIBORI Ryosuke  内堀 亮介

Less
Researcher Number 20458285
Other IDs
Affiliation (Current) 2025: 自治医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help 2021: 自治医科大学, 医学部, 講師
2019: 自治医科大学, 医学部, 講師
2016 – 2017: 自治医科大学, 医学部, 講師
2011 – 2014: 自治医科大学, 医学部, 助教
2009 – 2010: 自治医科大学, 医学部, 研究員
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics / Tumor immunology
Except Principal Investigator
Hematology
Keywords
Principal Investigator
キメラ抗原受容体 / 造血器腫瘍 / 多発性骨髄腫 / CAR / エリスロポエチン / CAR-T療法 / B細胞性リンパ腫 / SRG / 選択的制御遺伝子 / がん免疫療法 … More / 養子免疫療法 / 遺伝子治療 / 細胞療法 / 養子免疫遺伝子細胞治療 / BCMA / CD269 / 分子スイッチ / シグナル伝達 / がん / 細胞・遺伝子治療 … More
Except Principal Investigator
遺伝子治療 / 血液腫瘍学 / 造血器腫瘍 / Tリンパ球 / キメラ抗原受容体 / 細胞療法 / 免疫療法 / ゲノム / 移植再生医療 / 癌 / 間葉系幹細胞 Less
  • Research Projects

    (5 results)
  • Research Products

    (74 results)
  • Co-Researchers

    (6 People)
  •  Development of selective regulatory system for proliferation and persistence of CAR-T cellsPrincipal Investigator

    • Principal Investigator
      Uchibori Ryosuke
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Jichi Medical University
  •  Development of CD269-CAR T cells for the adoptive immunotherapy of multiple myeloma.Principal Investigator

    • Principal Investigator
      Uchibori Ryosuke
    • Project Period (FY)
      2016 – 2017
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Jichi Medical University
  •  Development of gene therapy for refractory non-Hodgkin lymphoma using T-cells expressing a chimeric antigen receptor

    • Principal Investigator
      OZAWA keiya
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Hematology
    • Research Institution
      Jichi Medical University
  •  Development of switch promoters driven by activation signals from the chimeric antigen receptors.Principal Investigator

    • Principal Investigator
      UCHIBORI Ryosuke
    • Project Period (FY)
      2012 – 2013
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Tumor immunology
    • Research Institution
      Jichi Medical University
  •  Development of gene therapy using bone-marrow-derived mesenchymal stem cells

    • Principal Investigator
      OZAWA Keiya
    • Project Period (FY)
      2009 – 2011
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Hematology
    • Research Institution
      Jichi Medical University

All 2019 2018 2017 2016 2015 2014 2013 2011 2010 2009 Other

All Journal Article Presentation

  • [Journal Article] CAR-T cell(キメラ抗原受容体発現T細胞)Therapy2018

    • Author(s)
      内堀亮介, 小澤敬也
    • Journal Title

      医薬ジャーナル

      Volume: 54 Pages: 79-85

    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Journal Article] 多発性骨髄腫に対するキメラ抗原受容体T 細胞療法の可能性2017

    • Author(s)
      内堀亮介
    • Journal Title

      血液内科

      Volume: 74 Pages: 392-397

    • NAID

      40021144514

    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Journal Article] 多発性骨髄腫に対するCAR-T細胞療法の開発研究2017

    • Author(s)
      内堀亮介
    • Journal Title

      血液フロンティア

      Volume: 27 Pages: 49-56

    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Journal Article] The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies2015

    • Author(s)
      Tsukahara, T., Iwase, N., Kawakami, K., Iwasaki, M., Yamamoto, C., Ohmine, K., Uchibori, R., Teruya, T., Ido, H., Saga, Y., Urabe, M., Mizukami, H., Kume, A., Nakamura, M., Brentjens, R., and Ozawa, K.
    • Journal Title

      Gene Therapy

      Volume: 22 Issue: 2 Pages: 209-215

    • DOI

      10.1038/gt.2014.104

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-23241063, KAKENHI-PROJECT-24390247, KAKENHI-PROJECT-25430155, KAKENHI-PROJECT-26430168
  • [Journal Article] Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells2014

    • Author(s)
      Uehara T, Kanazawa T, Mizukami H, Uchibori R, Tsukahara T, Urabe M, Kume A, Misawa K, Carey T, Suzuki M, Ichimura K, Ozawa K
    • Journal Title

      Cancer Science

      Volume: 105 Issue: 1 Pages: 72-80

    • DOI

      10.1111/cas.12315

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-23591548, KAKENHI-PROJECT-24390247, KAKENHI-PROJECT-24592594, KAKENHI-PROJECT-25430155, KAKENHI-PROJECT-25461460
  • [Journal Article] Cancer gene therapy using mesenchymal stem cells.2014

    • Author(s)
      Uchibori R, Tsukahara T, Ohmine K, Ozawa K.
    • Journal Title

      Int J Hematol.

      Volume: 99 Issue: 4 Pages: 377-82

    • DOI

      10.1007/s12185-014-1537-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24390247, KAKENHI-PROJECT-25430155, KAKENHI-PROJECT-26430168
  • [Journal Article] IL-21 is not necessary for anti-lymphoma effects of T cells expressing second-generation CD19-specific chimeric antigen receptors in a xenograft mouse model.2014

    • Author(s)
      Yamamoto C, Tsukahara T, Omine K, Teruya T, Ido H, Uchibori R, Urabe M, Mizukami H, Kume A, Nakamura M, Ozawa K.
    • Journal Title

      Jichi Medical University Journal

      Volume: 36 Pages: 23-31

    • NAID

      120006408261

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Journal Article] NF-κB activity regulates mesenchymal stem cell accumulation at tumor sites.2013

    • Author(s)
      Uchibori R, Tsukahara T, Mizuguchi H, Saga Y, Urabe M, Mizukami H, Kume A, Ozawa K
    • Journal Title

      Cancer Research

      Volume: 73 Issue: 1 Pages: 364-372

    • DOI

      10.1158/0008-5472.can-12-0088

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591548, KAKENHI-PROJECT-23659493, KAKENHI-PROJECT-24390247, KAKENHI-PROJECT-24700995, KAKENHI-PROJECT-25430155
  • [Journal Article] CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models2013

    • Author(s)
      Tsukahara T, Ohmine K, Yamamoto C, Uchibori R, Ido H, Teruya T, Urabe M, Mizukami H, Kume A, Nakamura M, Mineno J, Takesako K, Riviere I, Sadelain M, Brentjens R, Ozawa K
    • Journal Title

      Biochemical and Biophysical Research Communications

      Volume: 438 Issue: 1 Pages: 84-89

    • DOI

      10.1016/j.bbrc.2013.07.030

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591548, KAKENHI-PROJECT-24390247, KAKENHI-PROJECT-24700995, KAKENHI-PROJECT-25430155
  • [Journal Article] Establishment and characterization of transplantable, luminescence labeled rat renal cell carcinoma cell lines2010

    • Author(s)
      Kobayashi M, Murakami T, Uchibori R, Chun NA, Kobayashi E, Morita T, Ozawa K.
    • Journal Title

      J Urol

      Volume: 183巻 Pages: 2029-2035

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Journal Article] 間葉系幹細胞を用いたがん標的化療法2010

    • Author(s)
      Uchibori, R.
    • Journal Title

      臨床血液

      Volume: 51 Pages: 1641-6

    • NAID

      10027751339

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Journal Article] Scalable purification of adeno-associated virus serotype 1(AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes2009

    • Author(s)
      Okada T, Nonaka-Sarukawa M, Uchibori R, Kinoshita K, Hayashita-Kinoh H, Nitahara-Kasahara Y, Takeda S, and Ozawa K
    • Journal Title

      Hum. Gene Ther

      Volume: 20巻 Pages: 1013-1021

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Journal Article] Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy2009

    • Author(s)
      Uchibori R, Okada T, Ito T, Mizukami H, Kume A and Ozawa, K
    • Journal Title

      J. Gene Med

      Volume: 11巻 Pages: 373-381

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Journal Article] Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.2009

    • Author(s)
      Uchibori, R.
    • Journal Title

      J.Gene Med. 46

      Pages: 373-381

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Analysis of RetroNectin-Mediated T-Cell Activation on Expansion and Phenotype of Chimeric Antigen Receptor T Cells2019

    • Author(s)
      Ryosuke Uchibori、 Ken Ohmine、Junichi Mineno、Keiya Ozawa
    • Organizer
      The 10th Meeting of ACTO
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K07714
  • [Presentation] CAR-T therapy for multiple myeloma.2017

    • Author(s)
      Uchibori R.
    • Organizer
      The 23rd Annual Meeting of the Japan Society of Gene Therapy.
    • Invited
    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Presentation] CD269(BCMA)を標的とした多発性骨髄腫に対するCAR-T療法2017

    • Author(s)
      内堀 亮介
    • Organizer
      第23回血液科学セミナー
    • Invited
    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Presentation] AR-T療法の基礎2017

    • Author(s)
      内堀 亮介
    • Organizer
      第32回悪性リンパ腫治療研究会
    • Invited
    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Presentation] CD269-CAR-T therapy for bone lesions in myeloma model mice.2017

    • Author(s)
      Uchibori R, Ohmine K, Mineno J, Takesako K, and Ozawa K.
    • Organizer
      The 8th JSH International Symposium.
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Presentation] Effect of CAR-T therapy on bone lesions in an orthotopic multiple myeloma mouse model.2017

    • Author(s)
      Uchibori R, Ohmine K, Sehara Y, Urabe M, Mizukami H, Mineno J, Takesako K, and Ozawa K.
    • Organizer
      20th Annual Meeting of the American Society of Gene & Cell Therapy.
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Presentation] CD269-targeted CAR-modified T cells showed promising therapeutic efficacy in an orthotopic mouse model of multiple myeloma.2016

    • Author(s)
      Ryosuke Uchibori, Takeshi Teruya, Ken Ohmine, Masashi Urabe, Yasushi Saga, Hiroaki Mizukami, Junichi Mineno, and Keiya Ozawa.
    • Organizer
      第22回日本遺伝子細胞治療学会
    • Place of Presentation
      虎ノ門ヒルズフォーラム(東京都、港区)
    • Year and Date
      2016-07-28
    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Presentation] CD269 (BCMA)-specific CAR-expressing T cells dramatically eradicate myeloma cells from bone marrow of an orthotopic multiple myeloma mouse model.2016

    • Author(s)
      Ryosuke Uchibori, Takeshi Teruya, Ken Ohmine, Masashi Urabe, Yasushi Saga, Hiroaki Mizukami, Junichi Mineno, Kazuto Takesako, and Keiya Ozawa.
    • Organizer
      The 19th Annual Meeting of the American Society of Gene & Cell Therapy
    • Place of Presentation
      Washington, D.C., USA.
    • Year and Date
      2016-05-05
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Presentation] Therapeutic efficacy of CD269-targeted CAR-modified T cells in an orthotopic mouse model of multiple myeloma.2016

    • Author(s)
      Ryosuke Uchibori, Ken Ohmine, Masashi Urabe, Hiroaki Mizukami, Junichi Mineno, and Keiya Ozawa.
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(神奈川県、横浜市)
    • Year and Date
      2016-10-08
    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Presentation] Assessment of the efficacy and safety of CD269-specific CAR-expressing T cells using an orthotopic multiple myeloma mouse model.2016

    • Author(s)
      Ryosuke Uchibori, Takeshi Teruya, Ken Ohmine, Junichi Mineno, Kazuto Takesako, and Keiya Ozawa.
    • Organizer
      The 7th JSH International Symposium
    • Place of Presentation
      淡路夢舞台(兵庫県、淡路市)
    • Year and Date
      2016-05-13
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Presentation] Efficacy of adoptive immunotherapy with 269-CAR T cells in an orthotopic NOG mouse-human tumor xenograft model.2016

    • Author(s)
      内堀 亮介、照屋 武志、大嶺 謙、峰野 純一、小澤 敬也
    • Organizer
      第8回血液疾患免疫療法学会
    • Place of Presentation
      北海道大学医学部学友会館(北海道、札幌市)
    • Year and Date
      2016-09-03
    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Presentation] Therapeutic efficacy of CD269-specific CAR T cells in an orthotopic mouse model of multiple myeloma.2016

    • Author(s)
      Ryosuke Uchibori, Takeshi Teruya, Ken Ohmine, Masashi Urabe, Yasushi Saga, Hiroaki Mizukami, Junichi Mineno, and Keiya Ozawa.
    • Organizer
      第78回日本血液学会学術集会
    • Place of Presentation
      パシフィコ横浜(神奈川県、横浜市)
    • Year and Date
      2016-10-14
    • Data Source
      KAKENHI-PROJECT-16K18459
  • [Presentation] キメラ抗原受容体からの抗原刺激特異的な遺伝子発現誘導系の開発.2014

    • Author(s)
      内堀 亮介, 二宮 空暢, 照屋 武志, 塚原 智典, 大嶺 謙, 峰野 純一, 竹迫 一任, 小澤 敬也.
    • Organizer
      第6回血液疾患免疫療法研究会
    • Place of Presentation
      京都
    • Year and Date
      2014-09-06
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] Generation of T-cells expressing a CD19-specific CAR by the Tol2 transposon system.2014

    • Author(s)
      Tsukahara T, Ohmine K, Uchibori R, Urabe M, Mizukami H, Kume A, Nakamura M, Ozawa K.
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-09-25
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] The NFAT response elements in the IL-2 gene promoter permit visualization and quantification of activation status in CAR-expressing PBMCs.2014

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ido H, Teruya T, Ohmine K, Urabe M, Mizukami H, Kume A, Riviere I, Sadelain M, Brentjens RJ, Mineno J, Ozawa K.
    • Organizer
      第20回日本遺伝子治療学会
    • Place of Presentation
      東京
    • Year and Date
      2014-08-08
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] Activation signals from CAR permit NFAT-controlled inducible expression of transgenes in PBMCs.2014

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ido H, Teruya T, Ohmine K, Urabe M, Mizukami H, Kume A, Riviere I, Sadelain M, Brentjens RJ, Mineno J, Ozawa K.
    • Organizer
      第76回日本血液学会学術集会
    • Place of Presentation
      大阪
    • Year and Date
      2014-11-02
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] Tol2 transposon-based gene transfer of CD19-specific chimeric antigen receptors into human T-cells.2014

    • Author(s)
      Tsukahara T, Iwase N, Yamamoto C, Ohmine K, Uchibori R, Teruya T, Ido H, Urabe M, Mizukami H, Kume A, Nakamura M, Brentjens R, Kawakami K and Ozawa K.
    • Organizer
      第76回日本血液学会学術集会
    • Place of Presentation
      大阪
    • Year and Date
      2014-11-02
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] Activation signals from chimeric antigen receptors permit NFAT-controlled inducible expression of transgene in PBMCs.2014

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ido H, Teruya T, Ohmine K, Urabe M, Mizukami H, Kume A, Mineno J, Ozawa K.
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-09-26
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] Analysis of function and response specificity of a switch promoter driven by activation signals from a CD19-targeted chimeric antigen receptor.2014

    • Author(s)
      Uchibori R, Takeshi T, Tsukahara T, Ohmine K, Riviere I, Brentjens RJ, Sadelain M, Mineno J, Takesako K, Ozawa K.
    • Organizer
      The 5th Meeting of Asian Cellular Therapy Organization.
    • Place of Presentation
      大阪
    • Year and Date
      2014-11-11
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] Development of switch promoters that is activated to induce exogenous gene expression upon the recognition of CD19 by chimeric antigen receptors.2014

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ido H, Teruya T, Ohmine K, Urabe M, Mizukami H, Kume A, Riviere I, Sadelain M, Brentjens RJ, Mineno J, Ozawa K.
    • Organizer
      17th Annual Meeting of the American Society of Gene & Cell Therapy.
    • Place of Presentation
      Washington, D.C.
    • Year and Date
      2014-05-22
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] Tol2 transposon-mediated gene transfer of CD19-CAR to primary human T-cells for the treatment of B-cell malignancies.2014

    • Author(s)
      Tsukahara T, Iwase N, Yamamoto C, Ohmine K, Uchibori R, Takeshi T, Urabe M, Mizukami H, Kume A, Nakamura M, Brentjens R J, Kawakami K, Ozawa K.
    • Organizer
      第20回日本遺伝子治療学会
    • Place of Presentation
      東京
    • Year and Date
      2014-08-08
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] Development of switch promoters driven by activation signals from the chimeric antigen receptors2013

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ohmine K, Urabe M, Mizukami H, Kume A, Mineno J, Ozawa K
    • Organizer
      第75回日本血液学会学術集会
    • Place of Presentation
      札幌
    • Year and Date
      2013-10-12
    • Data Source
      KAKENHI-PROJECT-24700995
  • [Presentation] DEVELOPMENT OF SIN RETROVIRAL VECTORS EQUIPPED WITH SWITCH PROMOTERS DRIVEN BY ACTIVATION SIGNALS FROM THE CHIMERIC ANTIGEN RECEPTORS2013

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ido H, Teruya T, Ohmine K, Urabe M, Mizukami H, Kume A, Riviere I, Sadelain M, Brentjens RJ, Mineno J, Ozawa K
    • Organizer
      第18回日本遺伝子治療学会
    • Place of Presentation
      岡山
    • Year and Date
      2013-07-06
    • Data Source
      KAKENHI-PROJECT-24700995
  • [Presentation] Development of switch promoters that would respond to activation signals from the chimeric antigen receptors2013

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ido H, Teruya T, Ohmine K, Urabe M, Mizukami H, Kume A, Riviere I, Sadelain M, Brentjens RJ, Mineno J, Ozawa K
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2013-10-05
    • Data Source
      KAKENHI-PROJECT-24700995
  • [Presentation] Synergistic effect on the tumor-killing activity of soluble TRAIL-expressing MSCs2011

    • Author(s)
      Uchibori R
    • Organizer
      第70回に本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(名古屋)
    • Year and Date
      2011-10-04
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Enhancement of Tumor-Killing Activity of TRAIL-Expressing MSCs by Using Trichostatin A2011

    • Author(s)
      Uchibori R
    • Organizer
      The 14th Annual Meeting of the American Society of Gene and Cell Therapy
    • Place of Presentation
      The Washington State Convention Center(Seattle)
    • Year and Date
      2011-05-20
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Synergistic effect on the tumor-killing activity of soluble TRAIL-expressing MSCs2011

    • Author(s)
      Uchibori, R.
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(名古屋)
    • Year and Date
      2011-10-04
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Trichostatin A sensitize apoptosis induced by soluble TRAIL-expressing MSCs2011

    • Author(s)
      Uchibori, R.
    • Organizer
      The 17^<th> Annual Meeting of the Japan Society of Gene Therapy
    • Place of Presentation
      九州大学医学部百年講堂(福岡)
    • Year and Date
      2011-07-16
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Trichostatin A sensitize apoptosis induced by soluble TRAIL-expressing MSCs2011

    • Author(s)
      Uchibori R
    • Organizer
      The 17th Annual Meeting of the Japan Society of Gene Therapy
    • Place of Presentation
      九州大学医学部百年講堂(福岡)
    • Year and Date
      2011-07-16
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Enhancement of Tumor-Killing Activity of TRAIL-Expressing MSCs by Using Trichostatin A2011

    • Author(s)
      Uchibori, R.
    • Organizer
      The 14^<th> Annual Meeting of the American Society of Gene and Cell Therapy
    • Place of Presentation
      The Washington State Convention Center (Seattle)
    • Year and Date
      2011-05-20
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] The effect of DMXAA (TNF-α inducer) on MSC accumulation at tumor sites.2010

    • Author(s)
      Uchibori, R.
    • Organizer
      第16回日本癌学会総会
    • Place of Presentation
      大阪国際会議場(大阪)
    • Year and Date
      2010-09-24
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] NF-κB activity regulates MSC accumulation at tumor sites2010

    • Author(s)
      Uchibori R
    • Organizer
      The 13th Annual Meeting of the American Society of Gene Therapy
    • Place of Presentation
      Marriott Wardman Park Hotel(Washington, D. C.)
    • Year and Date
      2010-05-20
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Mesenchymal stem cells as a cellular vehicle for cancer-targeted gene therapy2010

    • Author(s)
      Uchibori R
    • Organizer
      The 16th Annual Meeting of the Japan Society of Gene Therapy
    • Place of Presentation
      栃木県総合文化センター(宇都宮)
    • Year and Date
      2010-07-02
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] The effect of DMXAA(TNF-α inducer) on MSC accumulation at tumor sites2010

    • Author(s)
      Uchibori R
    • Organizer
      第16回日本癌学会総会
    • Place of Presentation
      大阪国際会議場(大阪)
    • Year and Date
      2010-09-24
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] NF-κB activity regulates MSC accumulation at tumor sites.2010

    • Author(s)
      Uchibori, R.
    • Organizer
      The 13^<th>Annual Meeting of the American Society of Gene Therapy
    • Place of Presentation
      Marriott Wardman Park Hotel (Washington, D.C.)
    • Year and Date
      2010-05-20
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Mesenchymal stem cells as a cellular vehicle for cancer-targeted gene therapy.2010

    • Author(s)
      Uchibori, R.
    • Organizer
      The 16^<th> Annual Meeting of the Japan Society of Gene Therapy
    • Place of Presentation
      栃木県総合文化センター(宇都宮)
    • Year and Date
      2010-07-02
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] The effect of DMXAA(56-dimethylxanthenone-4-acetic acid) on MSC accumulation in tumor sites2010

    • Author(s)
      Uchibori R
    • Organizer
      The 16th Annual Meeting of the Japan Society of Gene Therapy
    • Place of Presentation
      栃木県総合文化センター(宇都宮)
    • Year and Date
      2010-07-01
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] The effect of DMXAA (56-dimethylxanthenone-4-acetic acid) on MSC accumulation in tumor sites.2010

    • Author(s)
      Uchibori, R.
    • Organizer
      The 16^<th> Annual Meeting of the Japan Societyof Gene Therapy
    • Place of Presentation
      栃木県総合文化センター(宇都宮)
    • Year and Date
      2010-07-01
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Roles of inflammatory cytokines in tumor tropism of mesenchimal stromal cells2009

    • Author(s)
      Uchibori R
    • Organizer
      The 12th Annual Meeting of the American Society of Gene Therapy
    • Place of Presentation
      San Diego Convention Center(San Diego)
    • Year and Date
      2009-05-28
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Cancer-targeted gene therapy using MSCs as a platform2009

    • Author(s)
      Uchibori R
    • Organizer
      Annual Meeting of the International Society for Cell and Gene Therapy of Cancer
    • Place of Presentation
      Ireland
    • Year and Date
      2009-09-03
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] VCAM-1 expression following TNF-alpha stimulation is required for tumor tropism of mesenchymal stem cells2009

    • Author(s)
      Uchibori, R.
    • Organizer
      第68回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Year and Date
      2009-10-03
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Mesenchymal stem cells(MSCs)as a platform for cancer gene therapy2009

    • Author(s)
      Uchibori, R.
    • Organizer
      第71回日本血液学会学術集会
    • Place of Presentation
      国立京都国際会館(京都)
    • Year and Date
      2009-10-23
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Mechanism of MSC(Mesenchymal stem/stromal cell) accumulation at tumor sites2009

    • Author(s)
      Uchibori R
    • Organizer
      The 15th Annual Meeting of the Japan Society of Gene Therapy
    • Place of Presentation
      大阪大学コンベンションセンター(大阪)
    • Year and Date
      2009-07-11
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Rloe of TNF-α in the MSC accumulation at tumor sites.2009

    • Author(s)
      Uchibori, R.
    • Organizer
      The 7^<th> Stem Cell Research Symposium
    • Place of Presentation
      Izumi Garden Gallery(Tokyo)
    • Year and Date
      2009-05-15
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Roles of inflammatory cytokines in tumor tropism of mesenchimal stromal cells.2009

    • Author(s)
      Uchibori, R.
    • Organizer
      The 12^<th> Annual Meeting of the American Society of Gene Therapy
    • Place of Presentation
      San Diego Convention Center(San Diego)
    • Year and Date
      2009-05-28
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] VCAM-1 expression following TNF-alpha stimulation is required, for tumor tropism of mesenchymal stem cells2009

    • Author(s)
      Uchibori R
    • Organizer
      第68回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Year and Date
      2009-10-03
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Mesenchymal stem cells(MSCs) as a platform for cancer gene therapy2009

    • Author(s)
      Uchibori R
    • Organizer
      第71回日本血液学会学術集会
    • Place of Presentation
      国立京都国際会館(京都)
    • Year and Date
      2009-10-23
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Cancer-targeted gene therapy using MSCs as a platform.2009

    • Author(s)
      Uchibori, R.
    • Organizer
      Annual Meeting of the International Society for Cell and Gene Therapy of Cancer
    • Place of Presentation
      Ireland
    • Year and Date
      2009-09-03
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Mechanism of MSC(Mesenchymal stem/stromal cell)accumulation at tumor sites.2009

    • Author(s)
      Uchibori, R.
    • Organizer
      The 15^<th> Annual Meeting of the Japan Society of Gene Therapy
    • Place of Presentation
      大阪大学コンベンションセンター(大阪)
    • Year and Date
      2009-07-11
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Mechanism of MSC(mesenchymal stem/stromal cell)accumulation at the sites of tumors.2009

    • Author(s)
      Uchibori R
    • Organizer
      The 14^<th> Congress of the European Hematology Association
    • Place of Presentation
      Germany
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Mechanism of MSC(mesenchymal stem/stromal cell) accumulation at the sites of tumors2009

    • Author(s)
      Uchibori R
    • Organizer
      The 14th Congress of the European Hematology Association
    • Place of Presentation
      Germany
    • Data Source
      KAKENHI-PROJECT-21390296
  • [Presentation] Development of switch promoters driven by activation signals from the chimeric antigen receptors.

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ohmine K, Urabe M, Mizukami H, Kume A, Mineno J, Ozawa K.
    • Organizer
      第75回日本血液学会学術集会
    • Place of Presentation
      札幌
    • Data Source
      KAKENHI-PROJECT-24700995
  • [Presentation] Anti-tumor activity of CD19-specific chimeric antigen receptor-modified T-cells for B cell lymphoma.

    • Author(s)
      Tsukahara T, Ohmine K, Uchibori R, Ido H, Urabe M, Mizukami H, Kume A, Nakamura M, Ozawa K.
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜市
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] Tumor targeting and anti-tumor activity mediated by T-lymphocytes with an anti-CD19 CAR in human B-cell lymphoma models.

    • Author(s)
      Tsukahara T, Ohmine K, Uchibori R, Ido H, Urabe M, Mizukami H, Kume A, Nakamura M, Riviere I, Sadelain M, Brentjens R, Ozawa K.
    • Organizer
      第18回日本遺伝子治療学会
    • Place of Presentation
      岡山市
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] DEVELOPMENT OF SIN RETROVIRAL VECTORS EQUIPPED WITH SWITCH PROMOTERS DRIVEN BY ACTIVATION SIGNALS FROM THE CHIMERIC ANTIGEN RECEPTORS.

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ido H, Teruya T, Ohmine K, Urabe M, Mizukami H, Kume A, Riviere I, Sadelain M, Brentjens RJ, Mineno J, Ozawa K.
    • Organizer
      第18回日本遺伝子治療学会
    • Place of Presentation
      岡山
    • Data Source
      KAKENHI-PROJECT-24700995
  • [Presentation] Development of switch promoters that would respond to activation signals from the chimeric antigen receptors.

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ido H, Teruya T, Ohmine K, Urabe M, Mizukami H, Kume A, Riviere I, Sadelain M, Brentjens RJ, Mineno J, Ozawa K.
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Data Source
      KAKENHI-PROJECT-24700995
  • [Presentation] Tumor targeting using T-lymphocytes with an anti-CD19 chimeric antigen receptor for B cell lymphoma.

    • Author(s)
      Tsukahara T, Ohmine K, Uchibori R, Ido H, Urabe M, Mizukami H, Kume A, Nakamura M, Riviere I, Sadelain M, Brentjens R, Ozawa K.
    • Organizer
      第75回日本血液学会学術集会
    • Place of Presentation
      札幌市
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] DEVELOPMENT OF SIN RETROVIRAL VECTORS EQUIPPED WITH SWITCH PROMOTERS DRIVEN BY ACTIVATION SIGNALS FROM THE CHIMERIC ANTIGEN RECEPTORS.

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ido H, Teruya T, Ohmine K, Urabe M, Mizukami H, Kume A, Riviere I, Sadelain M, Brentjens RJ, Mineno J, Ozawa K.
    • Organizer
      第18回日本遺伝子治療学会
    • Place of Presentation
      岡山市
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] Development of switch promoters that would respond to activation signals from the chimeric antigen receptors.

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ido H, Teruya T, Ohmine K, Urabe M, Mizukami H, Kume A, Riviere I, Sadelain M, Brentjens RJ, Mineno J, Ozawa K.
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜市
    • Data Source
      KAKENHI-PROJECT-24390247
  • [Presentation] Development of switch promoters driven by activation signals from the chimeric antigen receptors.

    • Author(s)
      Uchibori R, Ninomiya S, Tsukahara T, Ohmine K, Urabe M, Mizukami H, Kume A, Mineno J, Ozawa K.
    • Organizer
      第75回日本血液学会学術集会
    • Place of Presentation
      札幌市
    • Data Source
      KAKENHI-PROJECT-24390247
  • 1.  OZAWA Keiya (30137707)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 20 results
  • 2.  URABE Masashi (40213516)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  TSUKAHARA Tomonori (10362120)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 17 results
  • 4.  OHMINE Ken (90316521)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 16 results
  • 5.  久米 晃啓
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 3 results
  • 6.  川上 浩一
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi